Sage Therapeutics Stock (NASDAQ: SAGE) stock price, news, charts, stock research, profile.
Open | $12.960 |
Close | $12.570 |
Volume / Avg. | 4.316M / 915.569K |
Day Range | 10.920 - 13.423 |
52 Wk Range | 15.060 - 59.990 |
Market Cap | $755.541M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 16 |
Short Interest | 21.59% |
Days to Cover | 11.01 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Sage Therapeutics (NASDAQ: SAGE) through any online brokerage.
Other companies in Sage Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), Cabaletta Bio (NASDAQ:CABA) and 89bio (NASDAQ:ETNB).
The latest price target for Sage Therapeutics (NASDAQ: SAGE) was reported by HC Wainwright & Co. on Wednesday, April 17, 2024. The analyst firm set a price target for 28.00 expecting SAGE to rise to within 12 months (a possible 122.75% upside). 44 analyst firms have reported ratings in the last year.
The stock price for Sage Therapeutics (NASDAQ: SAGE) is $12.57 last updated April 17, 2024 at 7:27 PM EDT.
There are no upcoming dividends for Sage Therapeutics.
Sage Therapeutics’s Q1 earnings are confirmed for Thursday, April 25, 2024.
There is no upcoming split for Sage Therapeutics.
Sage Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.